Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapy.

Heetla HW, Staal MJ, Proost JH, van Laar T.

Arch Phys Med Rehabil. 2014 Nov;95(11):2199-206. doi: 10.1016/j.apmr.2014.04.030. Epub 2014 Jun 2. Review.

PMID:
24893275
2.

A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity.

Heetla HW, Proost JH, Molmans BH, Staal MJ, van Laar T.

Br J Clin Pharmacol. 2016 Jan;81(1):101-12.

3.

Differential effect of baclofen on cortical and spinal inhibitory circuits.

Stetkarova I, Kofler M.

Clin Neurophysiol. 2013 Feb;124(2):339-45. doi: 10.1016/j.clinph.2012.07.005. Epub 2012 Aug 9.

PMID:
22877625
4.

Use of intrathecal baclofen therapy in ambulant children and adolescents with spasticity and dystonia of cerebral origin: a systematic review.

Pin TW, McCartney L, Lewis J, Waugh MC.

Dev Med Child Neurol. 2011 Oct;53(10):885-95. doi: 10.1111/j.1469-8749.2011.03992.x. Epub 2011 Jun 3. Review. Erratum in: Dev Med Child Neurol. 2011 Nov;53(11):1065.

5.

Limitations of intrathecal baclofen for spastic hemiparesis following stroke.

Kofler M, Quirbach E, Schauer R, Singer M, Saltuari L.

Neurorehabil Neural Repair. 2009 Jan;23(1):26-31. doi: 10.1177/1545968308317700. Epub 2008 Sep 16.

PMID:
18796543
6.

[Results of intrathecal baclofen therapy on spasticity in patients with brain injury].

Dénes Z, Klauber A, Both B, Lóránd E.

Ideggyogy Sz. 2012 Jul 30;65(7-8):243-8; discussion 248. Hungarian.

PMID:
23074844
8.

Neuromodulation using intrathecal baclofen therapy for spasticity and dystonia.

Uchiyama T, Nakanishi K, Fukawa N, Yoshioka H, Murakami S, Nakano N, Kato A.

Neurol Med Chir (Tokyo). 2012;52(7):463-9.

9.

Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.

Borrini L, Bensmail D, Thiebaut JB, Hugeron C, Rech C, Jourdan C.

Arch Phys Med Rehabil. 2014 Jun;95(6):1032-8. doi: 10.1016/j.apmr.2013.12.019. Epub 2014 Jan 6.

PMID:
24407102
10.

Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience.

Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN.

Arch Phys Med Rehabil. 1999 Jan;80(1):13-9. Erratum in: Arch Phys Med Rehabil 1999 Apr;80(4):474.

PMID:
9915366
11.

[Intrathecal baclofen therapy and management of severe spasticity].

Naito Y.

Brain Nerve. 2014 Sep;66(9):1049-55. Japanese.

PMID:
25200576
12.

[Intrathecal baclofen therapy to spasticity].

Mizusawa H.

Rinsho Shinkeigaku. 2007 Nov;47(11):951-3. Japanese.

PMID:
18210845
13.

Consensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticity.

Dan B, Motta F, Vles JS, Vloeberghs M, Becher JG, Eunson P, Gautheron V, Lütjen S, Mall V, Pascual-Pascual SI, Pauwels P, Røste GK.

Eur J Paediatr Neurol. 2010 Jan;14(1):19-28. doi: 10.1016/j.ejpn.2009.05.002. Epub 2009 Jun 21. Review.

PMID:
19541514
14.

Biopharmaceutics of intrathecal baclofen-loaded microparticles in a goat model.

Lagarce F, Faisant N, Desfontis JC, Marescaux L, Gautier F, Holopherne D, Rousselet MC, Menei P, Benoit JP.

Int J Pharm. 2005 Jul 14;298(1):68-79.

PMID:
15919163
15.

Intrathecal baclofen therapy in children.

Albright AL, Ferson SS.

Neurosurg Focus. 2006 Aug 15;21(2):e3. Review.

PMID:
16918224
16.
17.

Suppression of stretch reflex activity after spinal or systemic treatment with AMPA receptor antagonist NGX424 in rats with developed baclofen tolerance.

Oshiro M, Hefferan MP, Kakinohana O, Lukacova N, Sugahara K, Yaksh TL, Marsala M.

Br J Pharmacol. 2010 Nov;161(5):976-85. doi: 10.1111/j.1476-5381.2010.00954.x.

18.

Use of intrathecal baclofen for treatment of severe spasticity in selected patients with motor neuron disease.

Bethoux F, Boulis N, McClelland S 3rd, Willis MA, Hussain M, Machado A, Mychkovsky L, Stough D, Sutliff M, Pioro EP.

Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):828-33. doi: 10.1177/1545968313496325. Epub 2013 Jul 24.

PMID:
23884016
19.

Effect of concentration and mode of intrathecal baclofen administration on soleus H-reflex in patients with muscle hypertonia.

Stokic DS, Yablon SA.

Clin Neurophysiol. 2012 Nov;123(11):2200-4. doi: 10.1016/j.clinph.2012.04.007. Epub 2012 May 16.

PMID:
22595326
20.

Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives.

Natale M, Mirone G, Rotondo M, Moraci A.

Clin Neurol Neurosurg. 2012 May;114(4):321-5. doi: 10.1016/j.clineuro.2011.10.046. Epub 2011 Nov 21.

PMID:
22104692

Supplemental Content

Support Center